** India's Nifty pharma index .NIPHARM jumps 4.4% after U.S. President Donald Trump exempted the sector from reciprocal tariffs for now
** Index constituents Dr. Reddy's REDY.NS, Cipla CIPL.NS, Sun Pharma SUN.NS, Gland Pharma GLAD.NS jump 6.1%, 4.1%, 4.1% and 11.7%, respectively
** Trump imposed 26% reciprocal tariffs on Indian imports as part of his wider plan to levy a 10% baseline tariff on all imports from April 5, but the duties do not apply to certain goods, including pharmaceuticals
** U.S. imports nearly a third of Indian pharma products sold overseas
** 19 of the 20 index constituents trading higher on the day, benchmark Nifty 50 .NSEI trading 0.45% lower
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。